raloxifene has been researched along with carfilzomib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chinnaswamy, K; Delproposto, J; Hayes, DF; Hu, B; Hu, J; Liu, Z; Miao, B; Stuckey, J; Wang, M; Wang, S; Xu, F; Yang, CY | 1 |
1 other study(ies) available for raloxifene and carfilzomib
Article | Year |
---|---|
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER).
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; Drug Design; Drug Screening Assays, Antitumor; Humans; Ligands; Molecular Structure; Proteolysis; Pyrrolidines; Receptors, Estrogen; Structure-Activity Relationship; Thiophenes; Ubiquitin-Protein Ligases | 2019 |